Related references
Note: Only part of the references are listed.Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
Min Young Baek et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
Yasushi Shintani et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases
Tao Jiang et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming
Praveena S. Thiagarajan et al.
ONCOTARGET (2016)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
Stefan Zimmermann et al.
CANCER TREATMENT REVIEWS (2014)
EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases
Dongdong Luo et al.
TUMOR BIOLOGY (2014)
AXL kinase as a novel target for cancer therapy
Xiaoliang Wu et al.
ONCOTARGET (2014)
Higher Expression of Receptor Tyrosine Kinase Axl, and Differential Expression of its Ligand, Gas6, Predict Poor Survival in Lung Adenocarcinoma Patients
Masashi Ishikawa et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non-Small-Cell Lung Cancer
James W. Welsh et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
Paul W. Sperduto et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Non-Small Cell Lung Cancer
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
New Strategies for Treatment of ALK-Rearranged Non-Small Cell Lung Cancers
Takaaki Sasaki et al.
CLINICAL CANCER RESEARCH (2011)
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma
Hector Alvarez et al.
CANCER BIOLOGY & THERAPY (2010)
DIAGNOSIS-SPECIFIC PROGNOSTIC FACTORS, INDEXES, AND TREATMENT OUTCOMES FOR PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES: A MULTI-INSTITUTIONAL ANALYSIS OF 4,259 PATIENTS
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Differential Expression of Axl in Hepatocellular Carcinoma and Correlation With Tumor Lymphatic Metastasis
Ling He et al.
MOLECULAR CARCINOGENESIS (2010)
Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
Chih-Chen Hong et al.
CANCER LETTERS (2008)
AXL is a potential target for therapeutic intervention in breast cancer progression
Yi-Xiang Zhang et al.
CANCER RESEARCH (2008)
Clinical predictors of metastatic disease to the brain from non small cell lung carcinoma: Primary tumor size, cell type, and lymph node metastases
Amol Mujoomdar et al.
RADIOLOGY (2007)
Expression of Axl in lung adenocarcinoma and correlation with tumor progression
YS Shieh et al.
NEOPLASIA (2005)
FDA drug approval summary:: Erlotinib (Tarceva®) tablets
MH Cohen et al.
ONCOLOGIST (2005)
Intracellular signaling pathways involved in Gas6-Ax1-mediated survival of endothelial cells
I Hasanbasic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis
WP Lee et al.
ONCOGENE (2002)
Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion
A Wimmel et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
